Targeted therapeutic innovation to improve health and quality of life
Mironid has raised €46M across 2 funding rounds from 7 investors, most recently a Series B round in Aug 2026. Based in Newhouse, UK; founded 2015; active in Healthtech. Data as of 14 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
